«

»

Toward Better-Quality Compounded Drugs — An Update from the FDA

Five years ago, methylprednisolone acetate and other drugs compounded by the New England Compounding Center (NECC; Framingham, Mass.) and administered to patients throughout the United States caused a fungal meningitis outbreak involving more than 750 infections and at least 64 deaths. The extent…

Read the full post at The New England Journal of Medicine: Search Results in Health Policy and Reform
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive